News About: Pharm. Industry
British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire
British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire.
The biggest change due to Shire's entry is expected to be in the ADHD ...
Sales of famous nutritional supplements seem to decrease
On June 5, according to the sales analysis of frequent OTC products in the first quarter from major listed pharmaceutical companies, sales of famous nutritional supplements seem to decrease.
The sales of national rep...
The drug price of 'Jakabi' which is used in the treatment of myelofibrosis will be lowered about 40%
The drug price of 'Jakabi (ingredient ruxolitinib)' which is used in the treatment of a rare disease, myelofibrosis, will be lowered about 40%.
According to industry sources, on May 30, Novartis Korea submitted econo...
Celltrion announced that they will embark on the approval procedure of biosimilar 'Remsima' in the United States
On June 2, Celltrion announced that they will embark on the approval procedure of biosimilar 'Remsima' in the United States.
According to Celltrion, they plan to submit permission application for sales in the U.S. ba...
Recently, there are increasingly large numbers of examples that small bio-pharmaceutical company buy bigger pharmaceutical company
Recently, there are increasingly large numbers of examples that small bio-pharmaceutical company buy bigger pharmaceutical company. The M & A with the form of 'David and Goliath' is analyzed to prove increased status ...
Kwangdong Pharmaceutical announced that they will not participate in the bidding of Dream Pharma
On June 2, Kwangdong Pharmaceutical announced that they will not participate in the bidding of Dream Pharma, followed by JW JoongWae.
Therefore, the list of companies which participate in the bidding of Dream Pharma ...
The implementation of 'Illegal kickback Two-strike out system' in July has caused alarm among pharmaceutical community
The implementation of 'Illegal kickback Two-strike out system' in July has caused alarm among pharmaceutical community.
Each pharmaceutical company is concerning that "Our company may fail if we don't obey the law." ...
Multinational pharmaceutical companies seem to avoid entering into domestic market
Recently, according to industry official related to clinical trial, it was analyzed that domestic clinical trial has joined the ranks of advanced countries, but clinical trial may not activated as it used to be. The r...
Chong Kun Dang embarked on the patent challenge of Celebrex
Chong Kun Dang embarked on the patent challenge of Celebrex (Pfizer Korea) which is an absolute leader in the field analgesic and anti-inflammatory.
Celebrex is one of the cox-2 inhibitors for pain relief recording s...
The prescription cost of top multinational pharmaceutical companies shows increasing trend
According to the analysis of prescription cost of top 18 multinational pharmaceutical companies, their prescription cost from January to April 2014 increased by 4.5%, from 774.2 billion won in the previous year to 808...
